Sinomenine hydrochloride exerts antitumor outcome in ovarian cancer cells by inhibition of long non-coding RNA HOST2 expression

References

• Bohiltea RE, Ancar V, Radoi V, et al. Project for the national program of early diagnosis of endometrial cancer part II. J Med Life. 2015;8(4):423–431.
   PubMedGoogle Scholar
• Mizushima T, Miyamoto H. The role of androgen receptor signaling in ovarian cancer. Cells. 2019;8(2):176.
   PubMed Web of Science ®Google Scholar
• Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chester C, Dorigo O, Berek JS, et al. Immunotherapeutic approaches to ovarian cancer treatment. J Immunother Cancer. 2015;3(1):7.
   PubMed Web of Science ®Google Scholar
• Corradetti B, Pisano S, Conlan RS, et al. Nanotechnology and immunotherapy in ovarian cancer: tracing new landscapes. J Pharmacol Exp Ther. 2019;370(3):636.
   PubMed Web of Science ®Google Scholar
• Gockley A, Wright A. Living through ovarian cancer treatment: acute and long-term toxicities of chemotherapy for advanced-stage disease. Hematol Oncol Clin North Am. 2018;32(6):1073–1085.
   PubMed Web of Science ®Google Scholar
• He LG, Li XL, Zeng XZ, et al. Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation. Acta Pharmacol Sin. 2014;35(2):203–210.
   PubMed Web of Science ®Google Scholar
• Kok TW, Yue PY, Mak NK, et al. The anti-angiogenic effect of sinomenine. Angiogenesis. 2005;8(1):3–12.
   PubMedGoogle Scholar
• Gao B, Wu Y, Yang YJ, et al. Sinomenine exerts anticonvulsant profile and neuroprotective activity in pentylenetetrazole kindled rats: involvement of inhibition of NLRP1 inflammasome. J Neuroinflammation. 2018;15(1):152.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang W, Zheng B, et al. Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway. Neurochem Res. 2019;44(4):763–775.
   PubMed Web of Science ®Google Scholar
• Wang Q, Li XK. Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol. 2011;11(3):373–376.
   PubMed Web of Science ®Google Scholar
• Zhang D, Dong Y, Zhao Y, et al. Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response. Oncol Rep. 2018;40(5):2886–2895.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang X, Shi H, et al. Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget. 2016;7(11):12598–12611.
   PubMed Web of Science ®Google Scholar
• Tripathi MK, Doxtater K, Keramatnia F, et al. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discov Today. 2018;23(9):1635–1643.
   PubMed Web of Science ®Google Scholar
• Rangel LB, Sherman-Baust CA, Wernyj RP, et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 2003;22(46):7225–7232.
   PubMed Web of Science ®Google Scholar
• Gao Y, Meng H, Liu S, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015;24(3):841–852.
   PubMed Web of Science ®Google Scholar
• Li X, Wang K, Ren Y, et al. MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study. Cell death Dis. 2014;5:e1356.
   PubMed Web of Science ®Google Scholar
• Yamasaki H. Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama. 1976;30(1):1–20.
   PubMed Web of Science ®Google Scholar
• Li XJ, Yue PY, Ha WY, et al. Effect of sinomenine on gene expression of the IL-1 beta-activated human synovial sarcoma. Life Sci. 2006;79(7):665–673.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhou L, Zhang W, et al. Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Rep. 2010;3(1):51–56.
   PubMed Web of Science ®Google Scholar
• Lu XL, Zeng J, Chen YL, et al. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction. Int J Oncol. 2013;42(1):229–238.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–348.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jiao Y, Liu Y, et al. Sinomenine hydrochloride inhibits the metastasis of human glioblastoma cells by suppressing the expression of matrix metalloproteinase-2/-9 and reversing the endogenous and exogenous epithelial-mesenchymal transition. Int J Mol Sci. 2018;19(3):E844.
   PubMed Web of Science ®Google Scholar
• Yang H, Yin P, Shi Z, et al. Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo. Oncol Lett. 2016;11(1):411–418.
   PubMed Web of Science ®Google Scholar
• Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78(4):539–542.
   PubMed Web of Science ®Google Scholar
• Deng F, Ma YX, Liang L, et al. The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K/AKT/mTOR pathway. Biomed Pharmacother. 2018;97:1269–1274.
   PubMed Web of Science ®Google Scholar
• Liu RT, Cao JL, Yan CQ, et al. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721. Biosci Rep. 2017;37(2):BSR20160532.
   PubMed Web of Science ®Google Scholar
• Lu PW, Li L, Wang F, et al. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer. J Cell Biochem. 2018;119(6):4570–4580.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Kang H, et al. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis. Int J Mol Med. 2019;43(2):1049–1057.
   PubMed Web of Science ®Google Scholar
• An N, Cheng D. The long noncoding RNA HOST2 promotes gemcitabine resistance in human pancreatic cancer cells. Pathol Oncol Res. 2018. doi:10.1007/s12253-018-0486-5
   Google Scholar
• Zhang Y, Jia LG, Wang P, et al. The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines. Eur Rev Med Pharmacol Sci. 2019;23(6):2380–2390.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang MY, Chu Z, et al. Long non-coding RNA HOST2 enhances proliferation and metastasis in gastric cancer. Neoplasma. 2019;66(01):101–108.
   PubMed Web of Science ®Google Scholar